343: Turbulence at the FDA, Bluebird Bio's sale and young biotech VCs
The Readout Loud
Emergence of a New Generation of Biotech Venture Capitalists
This chapter explores the emergence of a new generation of venture capitalists in the biotech sector, driven by technological advancements and the COVID-19 pandemic. It highlights the significance of founder-led ventures and introduces key firms shaping this dynamic landscape.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
